Providing EPCM Services for Manufacturing Plant in Switzerland
PASADENA, Calif.--(BUSINESS WIRE)--
Jacobs
Engineering Group Inc. (NYSE:JEC) announced today it was awarded a
contract to provide engineering, procurement and construction management
(EPCM) services for Biogen’s (NYSE: BIIB) new manufacturing facility in
Luterbach, Switzerland.
Under the terms of the agreement, Jacobs is providing EPCM services for
Biogen’s fourth manufacturing plant. Biogen discovers, develops and
delivers worldwide innovative therapies for people living with serious
neurological, autoimmune and rare diseases. The company currently
manufactures therapies in Cambridge, Massachusetts; Research Triangle
Park, North Carolina; and Hillerød, Denmark.
Plans for the new facility include state-of-the-art biotech
manufacturing technology, which is expected to triple the company’s
global capacity to produce large protein-based drugs known as biologics.
In making the announcement, Jacobs Global Life Sciences Senior Vice
President Robert Norfleet stated, “We are pleased Biogen chose to work
with us to meet its demands for increased manufacturing capacity. As the
largest professional services provider to the biopharmaceutical
industry, we look forward to providing innovative solutions that can
help strengthen its medication supply system around the globe.”
Work on the facility started in late 2015. The plant is expected to be in operation by 2019.
Founded in 1978, Biogen is one of the world’s oldest independent
biotechnology companies providing therapies for the treatment of
neurodegenerative diseases, hematologic conditions and autoimmune
disorders.
Jacobs is one of the world's largest and most diverse providers of
technical professional and construction services.
Statements made in this release that are not based on historical fact
are forward-looking statements. We base these forward-looking statements
on management’s current estimates and expectations as well as currently
available competitive, financial and economic data. Forward-looking
statements, however, are inherently uncertain. There are a variety of
factors that could cause business results to differ materially from our
forward-looking statements. For a description of some of the factors
which may occur that could cause actual results to differ from our
forward-looking statements please refer to our 2014 Form 10-K, and in
particular the discussions contained under Items 1 - Business, 1A - Risk
Factors, 3 - Legal Proceedings, and 7 - Management's Discussion and
Analysis of Financial Condition and Results of Operations. We do not
undertake to update any forward-looking statements made herein.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160105005401/en/
Source: Jacobs Engineering Group Inc.